Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
5.09
+0.05 (0.99%)
Apr 8, 2026, 4:00 PM EDT - Market closed
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $528.76 million as of April 8, 2026. Its market cap has increased by 226.26% in one year.
Market Cap
528.76M
Enterprise Value
395.98M
1-Year Change
226.26%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $528.76M, an increase of 366.36%. That is a compound annual growth rate of 30.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 523.57M | 60.56% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 522.48M |
| AgomAb Therapeutics NV | 522.46M |
| Upstream Bio | 516.99M |
| vTv Therapeutics | 510.90M |
| Rigel Pharmaceuticals | 508.57M |
| Contineum Therapeutics | 501.80M |
| Verastem | 494.51M |
| Lyell Immunopharma | 494.34M |